Medical Care
Global Diagnostic Imaging Clinical Trials Market Research Report 2025
- Mar 11, 25
- ID: 74788
- Pages: 85
- Figures: 86
- Views: 18
The global market for Diagnostic Imaging Clinical Trials was valued at US$ 1307 million in the year 2024 and is projected to reach a revised size of US$ 2046 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Diagnostic imaging clinical trials address questions about what type of imaging test will best detect disease when it is suspected or will help monitor known disease or monitor a therapy to evaluate whether it is working.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Clinical Trials.
The Diagnostic Imaging Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Imaging Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Imaging Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
Parexel
BioTelemetry
ERT
McLaren
Bioclinica
ProScan Imaging
Radiant Sage
Micron, Inc.
Imaging Endpoints
Intrinsic Imaging
Median Technologies
Segment by Type
Radiological Imaging Diagnosis
Non-radioactive Imaging Diagnosis
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diagnostic imaging clinical trials address questions about what type of imaging test will best detect disease when it is suspected or will help monitor known disease or monitor a therapy to evaluate whether it is working.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Clinical Trials.
The Diagnostic Imaging Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Imaging Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Imaging Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
Parexel
BioTelemetry
ERT
McLaren
Bioclinica
ProScan Imaging
Radiant Sage
Micron, Inc.
Imaging Endpoints
Intrinsic Imaging
Median Technologies
Segment by Type
Radiological Imaging Diagnosis
Non-radioactive Imaging Diagnosis
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiological Imaging Diagnosis
1.2.3 Non-radioactive Imaging Diagnosis
1.3 Market by Application
1.3.1 Global Diagnostic Imaging Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Clinical Trials Market Perspective (2020-2031)
2.2 Global Diagnostic Imaging Clinical Trials Growth Trends by Region
2.2.1 Global Diagnostic Imaging Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostic Imaging Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Diagnostic Imaging Clinical Trials Market Dynamics
2.3.1 Diagnostic Imaging Clinical Trials Industry Trends
2.3.2 Diagnostic Imaging Clinical Trials Market Drivers
2.3.3 Diagnostic Imaging Clinical Trials Market Challenges
2.3.4 Diagnostic Imaging Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue
3.1.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Diagnostic Imaging Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostic Imaging Clinical Trials Revenue
3.4 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Clinical Trials Revenue in 2024
3.5 Global Key Players of Diagnostic Imaging Clinical Trials Head office and Area Served
3.6 Global Key Players of Diagnostic Imaging Clinical Trials, Product and Application
3.7 Global Key Players of Diagnostic Imaging Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Clinical Trials Breakdown Data by Type
4.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Diagnostic Imaging Clinical Trials Breakdown Data by Application
5.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostic Imaging Clinical Trials Market Size (2020-2031)
6.2 North America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
6.4 North America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Imaging Clinical Trials Market Size (2020-2031)
7.2 Europe Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Imaging Clinical Trials Market Size (2020-2031)
9.2 Latin America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Diagnostic Imaging Clinical Trials Introduction
11.1.4 ICON Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.1.5 ICON Recent Development
11.2 Parexel
11.2.1 Parexel Company Details
11.2.2 Parexel Business Overview
11.2.3 Parexel Diagnostic Imaging Clinical Trials Introduction
11.2.4 Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.2.5 Parexel Recent Development
11.3 BioTelemetry
11.3.1 BioTelemetry Company Details
11.3.2 BioTelemetry Business Overview
11.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Introduction
11.3.4 BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.3.5 BioTelemetry Recent Development
11.4 ERT
11.4.1 ERT Company Details
11.4.2 ERT Business Overview
11.4.3 ERT Diagnostic Imaging Clinical Trials Introduction
11.4.4 ERT Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.4.5 ERT Recent Development
11.5 McLaren
11.5.1 McLaren Company Details
11.5.2 McLaren Business Overview
11.5.3 McLaren Diagnostic Imaging Clinical Trials Introduction
11.5.4 McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.5.5 McLaren Recent Development
11.6 Bioclinica
11.6.1 Bioclinica Company Details
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Diagnostic Imaging Clinical Trials Introduction
11.6.4 Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.6.5 Bioclinica Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Details
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Introduction
11.7.4 ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.7.5 ProScan Imaging Recent Development
11.8 Radiant Sage
11.8.1 Radiant Sage Company Details
11.8.2 Radiant Sage Business Overview
11.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Introduction
11.8.4 Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.8.5 Radiant Sage Recent Development
11.9 Micron, Inc.
11.9.1 Micron, Inc. Company Details
11.9.2 Micron, Inc. Business Overview
11.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Introduction
11.9.4 Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.9.5 Micron, Inc. Recent Development
11.10 Imaging Endpoints
11.10.1 Imaging Endpoints Company Details
11.10.2 Imaging Endpoints Business Overview
11.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Introduction
11.10.4 Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.10.5 Imaging Endpoints Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Details
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Introduction
11.11.4 Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Details
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Diagnostic Imaging Clinical Trials Introduction
11.12.4 Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.12.5 Median Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiological Imaging Diagnosis
1.2.3 Non-radioactive Imaging Diagnosis
1.3 Market by Application
1.3.1 Global Diagnostic Imaging Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Clinical Trials Market Perspective (2020-2031)
2.2 Global Diagnostic Imaging Clinical Trials Growth Trends by Region
2.2.1 Global Diagnostic Imaging Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostic Imaging Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Diagnostic Imaging Clinical Trials Market Dynamics
2.3.1 Diagnostic Imaging Clinical Trials Industry Trends
2.3.2 Diagnostic Imaging Clinical Trials Market Drivers
2.3.3 Diagnostic Imaging Clinical Trials Market Challenges
2.3.4 Diagnostic Imaging Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue
3.1.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Diagnostic Imaging Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostic Imaging Clinical Trials Revenue
3.4 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Clinical Trials Revenue in 2024
3.5 Global Key Players of Diagnostic Imaging Clinical Trials Head office and Area Served
3.6 Global Key Players of Diagnostic Imaging Clinical Trials, Product and Application
3.7 Global Key Players of Diagnostic Imaging Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Clinical Trials Breakdown Data by Type
4.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Diagnostic Imaging Clinical Trials Breakdown Data by Application
5.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostic Imaging Clinical Trials Market Size (2020-2031)
6.2 North America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
6.4 North America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Imaging Clinical Trials Market Size (2020-2031)
7.2 Europe Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Imaging Clinical Trials Market Size (2020-2031)
9.2 Latin America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Diagnostic Imaging Clinical Trials Introduction
11.1.4 ICON Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.1.5 ICON Recent Development
11.2 Parexel
11.2.1 Parexel Company Details
11.2.2 Parexel Business Overview
11.2.3 Parexel Diagnostic Imaging Clinical Trials Introduction
11.2.4 Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.2.5 Parexel Recent Development
11.3 BioTelemetry
11.3.1 BioTelemetry Company Details
11.3.2 BioTelemetry Business Overview
11.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Introduction
11.3.4 BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.3.5 BioTelemetry Recent Development
11.4 ERT
11.4.1 ERT Company Details
11.4.2 ERT Business Overview
11.4.3 ERT Diagnostic Imaging Clinical Trials Introduction
11.4.4 ERT Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.4.5 ERT Recent Development
11.5 McLaren
11.5.1 McLaren Company Details
11.5.2 McLaren Business Overview
11.5.3 McLaren Diagnostic Imaging Clinical Trials Introduction
11.5.4 McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.5.5 McLaren Recent Development
11.6 Bioclinica
11.6.1 Bioclinica Company Details
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Diagnostic Imaging Clinical Trials Introduction
11.6.4 Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.6.5 Bioclinica Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Details
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Introduction
11.7.4 ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.7.5 ProScan Imaging Recent Development
11.8 Radiant Sage
11.8.1 Radiant Sage Company Details
11.8.2 Radiant Sage Business Overview
11.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Introduction
11.8.4 Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.8.5 Radiant Sage Recent Development
11.9 Micron, Inc.
11.9.1 Micron, Inc. Company Details
11.9.2 Micron, Inc. Business Overview
11.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Introduction
11.9.4 Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.9.5 Micron, Inc. Recent Development
11.10 Imaging Endpoints
11.10.1 Imaging Endpoints Company Details
11.10.2 Imaging Endpoints Business Overview
11.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Introduction
11.10.4 Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.10.5 Imaging Endpoints Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Details
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Introduction
11.11.4 Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Details
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Diagnostic Imaging Clinical Trials Introduction
11.12.4 Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025)
11.12.5 Median Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiological Imaging Diagnosis
Table 3. Key Players of Non-radioactive Imaging Diagnosis
Table 4. Global Diagnostic Imaging Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diagnostic Imaging Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diagnostic Imaging Clinical Trials Market Share by Region (2020-2025)
Table 8. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diagnostic Imaging Clinical Trials Market Share by Region (2026-2031)
Table 10. Diagnostic Imaging Clinical Trials Market Trends
Table 11. Diagnostic Imaging Clinical Trials Market Drivers
Table 12. Diagnostic Imaging Clinical Trials Market Challenges
Table 13. Diagnostic Imaging Clinical Trials Market Restraints
Table 14. Global Diagnostic Imaging Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diagnostic Imaging Clinical Trials Market Share by Players (2020-2025)
Table 16. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2024)
Table 17. Ranking of Global Top Diagnostic Imaging Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diagnostic Imaging Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diagnostic Imaging Clinical Trials, Headquarters and Area Served
Table 20. Global Key Players of Diagnostic Imaging Clinical Trials, Product and Application
Table 21. Global Key Players of Diagnostic Imaging Clinical Trials, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diagnostic Imaging Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2020-2025)
Table 25. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2026-2031)
Table 27. Global Diagnostic Imaging Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2020-2025)
Table 29. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2026-2031)
Table 31. North America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 46. ICON Company Details
Table 47. ICON Business Overview
Table 48. ICON Diagnostic Imaging Clinical Trials Product
Table 49. ICON Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 50. ICON Recent Development
Table 51. Parexel Company Details
Table 52. Parexel Business Overview
Table 53. Parexel Diagnostic Imaging Clinical Trials Product
Table 54. Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 55. Parexel Recent Development
Table 56. BioTelemetry Company Details
Table 57. BioTelemetry Business Overview
Table 58. BioTelemetry Diagnostic Imaging Clinical Trials Product
Table 59. BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 60. BioTelemetry Recent Development
Table 61. ERT Company Details
Table 62. ERT Business Overview
Table 63. ERT Diagnostic Imaging Clinical Trials Product
Table 64. ERT Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 65. ERT Recent Development
Table 66. McLaren Company Details
Table 67. McLaren Business Overview
Table 68. McLaren Diagnostic Imaging Clinical Trials Product
Table 69. McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 70. McLaren Recent Development
Table 71. Bioclinica Company Details
Table 72. Bioclinica Business Overview
Table 73. Bioclinica Diagnostic Imaging Clinical Trials Product
Table 74. Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 75. Bioclinica Recent Development
Table 76. ProScan Imaging Company Details
Table 77. ProScan Imaging Business Overview
Table 78. ProScan Imaging Diagnostic Imaging Clinical Trials Product
Table 79. ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 80. ProScan Imaging Recent Development
Table 81. Radiant Sage Company Details
Table 82. Radiant Sage Business Overview
Table 83. Radiant Sage Diagnostic Imaging Clinical Trials Product
Table 84. Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 85. Radiant Sage Recent Development
Table 86. Micron, Inc. Company Details
Table 87. Micron, Inc. Business Overview
Table 88. Micron, Inc. Diagnostic Imaging Clinical Trials Product
Table 89. Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 90. Micron, Inc. Recent Development
Table 91. Imaging Endpoints Company Details
Table 92. Imaging Endpoints Business Overview
Table 93. Imaging Endpoints Diagnostic Imaging Clinical Trials Product
Table 94. Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 95. Imaging Endpoints Recent Development
Table 96. Intrinsic Imaging Company Details
Table 97. Intrinsic Imaging Business Overview
Table 98. Intrinsic Imaging Diagnostic Imaging Clinical Trials Product
Table 99. Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 100. Intrinsic Imaging Recent Development
Table 101. Median Technologies Company Details
Table 102. Median Technologies Business Overview
Table 103. Median Technologies Diagnostic Imaging Clinical Trials Product
Table 104. Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 105. Median Technologies Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Diagnostic Imaging Clinical Trials Picture
Figure 2. Global Diagnostic Imaging Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diagnostic Imaging Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Radiological Imaging Diagnosis Features
Figure 5. Non-radioactive Imaging Diagnosis Features
Figure 6. Global Diagnostic Imaging Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diagnostic Imaging Clinical Trials Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Diagnostic Imaging Clinical Trials Report Years Considered
Figure 12. Global Diagnostic Imaging Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diagnostic Imaging Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diagnostic Imaging Clinical Trials Market Share by Region: 2024 VS 2031
Figure 15. Global Diagnostic Imaging Clinical Trials Market Share by Players in 2024
Figure 16. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diagnostic Imaging Clinical Trials Revenue in 2024
Figure 18. North America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 20. United States Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 24. Germany Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diagnostic Imaging Clinical Trials Market Share by Region (2020-2031)
Figure 32. China Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 40. Mexico Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 44. Turkey Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ICON Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 48. Parexel Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 49. BioTelemetry Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 50. ERT Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 51. McLaren Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 52. Bioclinica Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 53. ProScan Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 54. Radiant Sage Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 55. Micron, Inc. Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 56. Imaging Endpoints Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 57. Intrinsic Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 58. Median Technologies Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiological Imaging Diagnosis
Table 3. Key Players of Non-radioactive Imaging Diagnosis
Table 4. Global Diagnostic Imaging Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diagnostic Imaging Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diagnostic Imaging Clinical Trials Market Share by Region (2020-2025)
Table 8. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diagnostic Imaging Clinical Trials Market Share by Region (2026-2031)
Table 10. Diagnostic Imaging Clinical Trials Market Trends
Table 11. Diagnostic Imaging Clinical Trials Market Drivers
Table 12. Diagnostic Imaging Clinical Trials Market Challenges
Table 13. Diagnostic Imaging Clinical Trials Market Restraints
Table 14. Global Diagnostic Imaging Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diagnostic Imaging Clinical Trials Market Share by Players (2020-2025)
Table 16. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2024)
Table 17. Ranking of Global Top Diagnostic Imaging Clinical Trials Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diagnostic Imaging Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diagnostic Imaging Clinical Trials, Headquarters and Area Served
Table 20. Global Key Players of Diagnostic Imaging Clinical Trials, Product and Application
Table 21. Global Key Players of Diagnostic Imaging Clinical Trials, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diagnostic Imaging Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2020-2025)
Table 25. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Type (2026-2031)
Table 27. Global Diagnostic Imaging Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2020-2025)
Table 29. Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Application (2026-2031)
Table 31. North America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
Table 46. ICON Company Details
Table 47. ICON Business Overview
Table 48. ICON Diagnostic Imaging Clinical Trials Product
Table 49. ICON Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 50. ICON Recent Development
Table 51. Parexel Company Details
Table 52. Parexel Business Overview
Table 53. Parexel Diagnostic Imaging Clinical Trials Product
Table 54. Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 55. Parexel Recent Development
Table 56. BioTelemetry Company Details
Table 57. BioTelemetry Business Overview
Table 58. BioTelemetry Diagnostic Imaging Clinical Trials Product
Table 59. BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 60. BioTelemetry Recent Development
Table 61. ERT Company Details
Table 62. ERT Business Overview
Table 63. ERT Diagnostic Imaging Clinical Trials Product
Table 64. ERT Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 65. ERT Recent Development
Table 66. McLaren Company Details
Table 67. McLaren Business Overview
Table 68. McLaren Diagnostic Imaging Clinical Trials Product
Table 69. McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 70. McLaren Recent Development
Table 71. Bioclinica Company Details
Table 72. Bioclinica Business Overview
Table 73. Bioclinica Diagnostic Imaging Clinical Trials Product
Table 74. Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 75. Bioclinica Recent Development
Table 76. ProScan Imaging Company Details
Table 77. ProScan Imaging Business Overview
Table 78. ProScan Imaging Diagnostic Imaging Clinical Trials Product
Table 79. ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 80. ProScan Imaging Recent Development
Table 81. Radiant Sage Company Details
Table 82. Radiant Sage Business Overview
Table 83. Radiant Sage Diagnostic Imaging Clinical Trials Product
Table 84. Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 85. Radiant Sage Recent Development
Table 86. Micron, Inc. Company Details
Table 87. Micron, Inc. Business Overview
Table 88. Micron, Inc. Diagnostic Imaging Clinical Trials Product
Table 89. Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 90. Micron, Inc. Recent Development
Table 91. Imaging Endpoints Company Details
Table 92. Imaging Endpoints Business Overview
Table 93. Imaging Endpoints Diagnostic Imaging Clinical Trials Product
Table 94. Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 95. Imaging Endpoints Recent Development
Table 96. Intrinsic Imaging Company Details
Table 97. Intrinsic Imaging Business Overview
Table 98. Intrinsic Imaging Diagnostic Imaging Clinical Trials Product
Table 99. Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 100. Intrinsic Imaging Recent Development
Table 101. Median Technologies Company Details
Table 102. Median Technologies Business Overview
Table 103. Median Technologies Diagnostic Imaging Clinical Trials Product
Table 104. Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2020-2025) & (US$ Million)
Table 105. Median Technologies Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Diagnostic Imaging Clinical Trials Picture
Figure 2. Global Diagnostic Imaging Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diagnostic Imaging Clinical Trials Market Share by Type: 2024 VS 2031
Figure 4. Radiological Imaging Diagnosis Features
Figure 5. Non-radioactive Imaging Diagnosis Features
Figure 6. Global Diagnostic Imaging Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diagnostic Imaging Clinical Trials Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Diagnostic Imaging Clinical Trials Report Years Considered
Figure 12. Global Diagnostic Imaging Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diagnostic Imaging Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diagnostic Imaging Clinical Trials Market Share by Region: 2024 VS 2031
Figure 15. Global Diagnostic Imaging Clinical Trials Market Share by Players in 2024
Figure 16. Global Top Diagnostic Imaging Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diagnostic Imaging Clinical Trials Revenue in 2024
Figure 18. North America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 20. United States Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 24. Germany Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diagnostic Imaging Clinical Trials Market Share by Region (2020-2031)
Figure 32. China Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 40. Mexico Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diagnostic Imaging Clinical Trials Market Share by Country (2020-2031)
Figure 44. Turkey Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diagnostic Imaging Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ICON Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 48. Parexel Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 49. BioTelemetry Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 50. ERT Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 51. McLaren Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 52. Bioclinica Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 53. ProScan Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 54. Radiant Sage Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 55. Micron, Inc. Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 56. Imaging Endpoints Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 57. Intrinsic Imaging Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 58. Median Technologies Revenue Growth Rate in Diagnostic Imaging Clinical Trials Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232